Navigation Links
A Settlement Over Stem Cell Controversy Through Scientific Research

The successful attempts of scientists to create stem cells that resemble those of the embryonic origin, in addition to reprogramming to the embryonic state could eliminate the need for creation and destruction of human embryos for the same. //

If future experiments are directed to ensure that this reprogrammed state would be maintained even after removal of the embryonic stem cell DNA, currently a technical hurdle, the hybrid cells could theoretically be used to produce embryonic stem cells lines that are tailored to individual patients without the need to exploit human embryos.

The hybrid cells created by the team had the appearance, growth rate, and several key genetic characteristics of human embryonic cells. They also behaved like embryonic cells, differentiating into cells from each of the three main tissue types that form in a developing embryo.

This would not only save the embryos from being used for scientific purposes but also eliminate the controversy that exists over stem cell research at the present, circumventing some of the logistical and societal concerns. The above study has used laboratory grown human embryonic stem cells that have already been approved for use by federally funded researchers.

Not much is known about the feasibility of the procedure presently, but has led to an understanding that human embryonic cells have the ability to reprogram adult cell chromosomes following cell fusion.
'"/>




Page: 1

Related medicine news :

1. Is Workers’ Comp. Settlements for Back Pain Fair
2. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
3. Herbal Drug In Controversy
4. The Existing Controversy of Hormone Replacement Therapy
5. Controversy over spread of Mad Cow disease from India
6. French Fries In Cancer Controversy In China
7. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
8. Controversy: Malaria Vaccine - Future Possibility Or Just A Dream?
9. The Looming Controversy Surrounding Facial Transplant
10. Controversy over Healthy diet may lead to less red meat in diet
11. Controversy over Copeman Healthcare fee
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ... animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at ... and joint health in horses at the immunologic level. , The scientifically-developed Flexadin ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the ... Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than ... marketer in the last 25 years. , Now, due to changes in the broadcast ...
(Date:4/24/2017)... Virginia (PRWEB) , ... April 24, 2017 , ... ... announced that they are seeking public support to bring their novel lifesaving device ... appearance, wearable device packed with medical-grade sensors, specially designed to read a child’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
Breaking Medicine Technology: